Prognostic value of anthropometric measures extracted from whole-body CT using deep learning in patients with non-small-cell lung cancer

Introduction The aim of the study was to extract anthropometric measures from CT by deep learning and to evaluate their prognostic value in patients with non-small-cell lung cancer (NSCLC). Methods A convolutional neural network was trained to perform automatic segmentation of subcutaneous adipose t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European radiology 2020-06, Vol.30 (6), p.3528-3537
Hauptverfasser: Blanc-Durand, Paul, Campedel, Luca, Mule, Sébastien, Jegou, Simon, Luciani, Alain, Pigneur, Frédéric, Itti, Emmanuel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction The aim of the study was to extract anthropometric measures from CT by deep learning and to evaluate their prognostic value in patients with non-small-cell lung cancer (NSCLC). Methods A convolutional neural network was trained to perform automatic segmentation of subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT), and muscular body mass (MBM) from low-dose CT images in 189 patients with NSCLC who underwent pretherapy PET/CT. After a fivefold cross-validation in a subset of 35 patients, anthropometric measures extracted by deep learning were normalized to the body surface area (BSA) to control the various patient morphologies. VAT/SAT ratio and clinical parameters were included in a Cox proportional-hazards model for progression-free survival (PFS) and overall survival (OS). Results Inference time for a whole volume was about 3 s. Mean Dice similarity coefficients in the validation set were 0.95, 0.93, and 0.91 for SAT, VAT, and MBM, respectively. For PFS prediction, T-stage, N-stage, chemotherapy, radiation therapy, and VAT/SAT ratio were associated with disease progression on univariate analysis. On multivariate analysis, only N-stage (HR = 1.7 [1.2–2.4]; p  = 0.006), radiation therapy (HR = 2.4 [1.0–5.4]; p  = 0.04), and VAT/SAT ratio (HR = 10.0 [2.7–37.9]; p  
ISSN:0938-7994
1432-1084
DOI:10.1007/s00330-019-06630-w